• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7308
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 04/08/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Due to the covid-19 pandemic, the investigation for this event will be delayed.We will however, send the follow-up report as soon as our laboratory services are able to return to normal.The patient/family was the initial reporter, so personal information was not entered.No information was captured as the customer's weight was not provided.This event is related to mdrs 1810909-2020-00243 and 1810909-2020-00244.
 
Event or Problem Description
The customer reported that she obtained a difference of 40-60 mg/dl between blood glucose readings obtained on the contour next ez meter and a different meter.No specific readings were provided.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.
 
Additional Manufacturer Narrative
The customer returned the suspected contour next ez meter and contour next test strips from lot # 9cpeg01b for evaluation.In-house testing was performed using the returned meter with returned test strips, which gave a satisfactory performance.The initial report indicated that this event was related to mdrs 1810909-2020-00243 and 1810909-2020-00244.This event is unrelated to the above mentioned reports and the information in section h10 of the initial report was captured inadvertently.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla, ny
MDR Report Key10055359
Report Number1810909-2020-00245
Device Sequence Number16852792
Product Code NBW
UDI-Device Identifier10301937308502
UDI-Public10301937308502
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K111268
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Nurse
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 04/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2021
Device Model Number7308
Device Catalogue Number7308
Device Lot Number9CPEG01B
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/09/2020
Initial Date Received by Manufacturer 04/20/2020
Supplement Date Received by Manufacturer07/09/2020
Initial Report FDA Received Date05/14/2020
Supplement Report FDA Received Date07/15/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age64 YR
-
-